I also share your enthusiasm, hell I brought the stock! Great potential, BUT, things are taking soooooo long. The scoping study for Juruena was to be released by the end of October 2015, then it was to be released by April 2016 -- I'm not hold my breath. And that's the thing that lets CAS down, if you don't think you can deliver on dates, then don't state them to start with, because people do expect that information to come out. For the SS to be further delayed from the original October date is becoming enbarassing. And I could name other areas where this sort of thing has been repeated. The only excuse management may have is that circumstances have changed, and this new direction had meant the delay or cancellation of the planned announcements. Well then, if that's the case, why can't they inform shareholders about that?
CAS Price at posting:
15.5¢ Sentiment: None Disclosure: Held
